Resistant starch reduces glycolysis by HK2 and suppresses high-fructose corn syrup-induced colon tumorigenesis
Journal of Gastroenterology · 2024
DOI: 10.1007/s00535-024-02138-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, 2024. Verfasst von Ying Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Glycolysis, High Fructose Corn Syrup, Colonic Neoplasms, Carcinogenesis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Medical and Health Science and Technology Project, Zhejiang Provincial Science and Technology Project.
Abstract (Originalsprache)
Background
The intake of high-fructose corn syrup (HFCS) may increase the risk of colorectal cancer (CRC). This study aimed to explore the potential effects and mechanisms of resistant starch (RS) in HFCS-induced colon tumorigenesis.
Methods
The azoxymethane/dextran sodium sulfate (AOM/DSS) and Apc Min/ + mice models were used to investigate the roles of HFCS and RS in CRC in vivo. An immunohistochemistry (IHC) staining analysis was used to detect the expression of proliferation-related proteins in tissues. 16S rRNA sequencing for microbial community, gas chromatography for short-chain fatty acids (SCFAs), and mass spectrometry analysis for glycolysis products in the intestines were performed. Furthermore, lactic acid assay kit was used to detect the glycolysis levels in vitro.
Results
RS suppressed HFCS-induced colon tumorigenesis through reshaping the microbial community. Mechanistically, the alteration of the microbial community after RS supplement increased the levels of intestinal SCFAs, especially butyrate, leading to the suppression of glycolysis and CRC cell proliferation by downregulating HK2.
Conclusions
Our study identified RS as a candidate of protective factors in CRC and may provide a potential target for HFCS-related CRC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
- Department of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Nutriology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. 3410001@zju.edu.cn.
- Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. chenshujie77@zju.edu.cn.
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Medical and Health Science and Technology Project
- Zhejiang Provincial Science and Technology Project
Zitieren
APA
Zhang, Y., Shen, W., Chen, Z., He, J., Feng, L., Wang, L., & Chen, S. (2024). Resistant starch reduces glycolysis by HK2 and suppresses high-fructose corn syrup-induced colon tumorigenesis. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02138-3
Vancouver
Zhang Y, Shen W, Chen Z, He J, Feng L, Wang L, et al. Resistant starch reduces glycolysis by HK2 and suppresses high-fructose corn syrup-induced colon tumorigenesis. Journal of Gastroenterology. 2024. doi:10.1007/s00535-024-02138-3
BibTeX
@article{Zhang2024,
author = {Zhang, Ying and Shen, Weiyi and Chen, Zhehang and He, Jiamin and Feng, Lijun and Wang, Lan and Chen, Shujie},
title = {Resistant starch reduces glycolysis by HK2 and suppresses high-fructose corn syrup-induced colon tumorigenesis},
journal = {Journal of Gastroenterology},
year = {2024},
doi = {10.1007/s00535-024-02138-3}
}
EUVIMED